Science · Open for opinions
Will a clinical trial for APOE4 vascular therapy be announced by 11/30/2026?
The recent discovery of reversible vascular damage caused by the APOE4 gene [5] paves the way for testing new therapeutic approaches. 76 opinions, 64% No
- Yes — 36%
- No — 64%
Deadline: November 30, 2026 at 11:59 PM UTC · 76 opinions
Resolution rules
The recent discovery of reversible vascular damage caused by the APOE4 gene [5] paves the way for testing new therapeutic approaches.
Source: vertexaisearch.cloud.google.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 03/10/2026 (00:00, horário de Brasília) até 30/11/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se a FDA, o Mount Sinai ou a plataforma ClinicalTrials.gov registrarem formalmente o início de ensaio clínico humano focado na reversão de dano vascular pelo gene APOE4 até 30/11/2026. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 64% of the votes: an opinion on it that turns out right earns about 36 points, a wrong one costs about 64.